Risk Factors and Preventive Measures for Lung Cancer in the European Union

TL;DR

This study explores factors linked to lung cancer mortality in EU countries and suggests strategies to reduce deaths.

Contribution

The study identifies key factors influencing lung cancer mortality and proposes targeted preventive measures.

Findings

Lung cancer mortality is strongly correlated with incidence rates, tobacco prices, and doctor availability.

Increasing physician numbers and drug accessibility could lower mortality.

Early detection through LDCT screening and healthcare optimization are recommended.

Abstract

Background: Lung cancer is worldwide one of the most common types of cancer with still very high mortality rates. The aim of this study was to identify and demonstrate correlations between lung cancer mortality rates and potential influencing factors in EU countries. Methods: This retrospective study investigated the connections between the mortality rates in the EU countries (n = 28) and potential influencing factors. The significant factors from the correlation analysis were identified using a stepwise multiple regression analysis. Results: The most important factors for both genders are the incidence of lung cancer, the price of tobacco, and the number of doctors per 100,000 inhabitants. Conclusion: Lung cancer is a significant global health challenge. The study identified potential strategies for reducing the mortality rate from lung cancer. These strategies include an increase in the number of physicians, enhanced accessibility to cutting-edge antineoplastic medications, and state-funded coverage of the associated costs. It would be beneficial for politicians to consider implementing LDCT screening for the early detection of the disease. The implementation of uniform healthcare system optimization across the EU, combined with improvements in socio-economic conditions, has the potential to mitigate the risk of developing lung cancer.